Top Vagus Nerve Stimulation Companies

The competitive landscape of the global vagus nerve stimulation (VNS) market is characterized by a blend of established medical device manufacturers, innovative start-ups, and strategic collaborations. Leading companies such as LivaNova PLC, ElectroCore LLC, and EnteroMedics Inc. dominate the market due to their extensive product portfolios, significant investments in R&D, and established market presence. These key players focus on continuous product development, technological advancements, and expanding their geographical reach to maintain a competitive edge.

The market also witnesses the active participation of emerging players, often specializing in specific segments of VNS devices or targeting niche applications. These entrants bring innovation and fresh perspectives, driving the evolution of VNS therapies. Collaborations between established players and start-ups are becoming common, aiming to leverage complementary strengths and accelerate the development of novel solutions.

Vagus Nerve Stimulation Market Top Player’s Company Profiles

• LivaNova PLC (United Kingdom)

• ElectroCore LLC (United States)

• EnteroMedics Inc. (United States)

• Boston Scientific Corporation (United States)

• NeuroMetrix Inc. (United States)

• Cyberonics, Inc. (a subsidiary of LivaNova PLC) (United States)

• SetPoint Medical Corporation (United States)

• Inspire Medical Systems, Inc. (United States)

• NeuroPace, Inc. (United States)

• NeuroSigma, Inc. (United States)

• Vagus Nerve Stimulation Ltd. (Israel)

• Endonovo Therapeutics, Inc. (United States)

• Nevro Corp. (United States)

• BioControl Medical (Israel)

• Helius Medical Technologies, Inc. (United States)

• Vivonics, Inc. (United States)

• Bioness Inc. (United States)

• Beijing Demax Medical Technology Co., Ltd. (China)

• Neurowave Systems Inc. (Canada)

• Nobel Biocare Services AG (Switzerland)